Walgreens Boots Alliance (WBA) Issues Earnings Results

Walgreens Boots Alliance (NASDAQ:WBA) announced its earnings results on Thursday. The pharmacy operator reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.43 by $0.03, Morningstar.com reports. The firm had revenue of $33.79 billion during the quarter, compared to analysts’ expectations of $33.90 billion. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. The company’s revenue was up 9.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.28 earnings per share. Walgreens Boots Alliance updated its FY 2019 guidance to $6.44-6.74 EPS and its FY19 guidance to $6.40-6.70 EPS.

Shares of WBA stock opened at $73.29 on Thursday. The firm has a market capitalization of $71.39 billion, a P/E ratio of 12.17, a PEG ratio of 1.18 and a beta of 0.76. Walgreens Boots Alliance has a one year low of $59.07 and a one year high of $86.31. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.82 and a quick ratio of 0.38.

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 12th. Investors of record on Monday, November 12th were given a $0.44 dividend. The ex-dividend date of this dividend was Thursday, November 8th. This represents a $1.76 annualized dividend and a yield of 2.40%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 29.24%.



Several research firms have recently weighed in on WBA. Pivotal Research increased their price objective on Walgreens Boots Alliance from $60.00 to $72.00 and gave the company a “hold” rating in a research report on Monday, October 15th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $92.00 price objective for the company in a research report on Friday, November 30th. Goldman Sachs Group cut Walgreens Boots Alliance from a “neutral” rating to a “sell” rating in a research report on Friday, December 14th. TheStreet raised Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research report on Wednesday, September 12th. Finally, Loop Capital increased their price objective on Walgreens Boots Alliance from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Friday, October 12th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and seven have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $79.11.

In related news, Director Nancy M. Schlichting sold 7,050 shares of the firm’s stock in a transaction on Tuesday, November 20th. The stock was sold at an average price of $78.81, for a total value of $555,610.50. Following the completion of the transaction, the director now directly owns 5,709 shares of the company’s stock, valued at $449,926.29. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of the firm’s stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total value of $4,096,040.00. Following the completion of the transaction, the executive vice president now directly owns 81,076 shares of the company’s stock, valued at $6,386,356.52. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 73,756 shares of company stock valued at $5,824,194. 15.73% of the stock is owned by company insiders.

A number of hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in shares of Walgreens Boots Alliance by 0.6% in the third quarter. Vanguard Group Inc. now owns 70,634,071 shares of the pharmacy operator’s stock valued at $5,149,224,000 after buying an additional 448,045 shares in the last quarter. Vanguard Group Inc increased its stake in shares of Walgreens Boots Alliance by 0.6% in the third quarter. Vanguard Group Inc now owns 70,634,071 shares of the pharmacy operator’s stock valued at $5,149,224,000 after buying an additional 448,045 shares in the last quarter. BlackRock Inc. increased its stake in shares of Walgreens Boots Alliance by 1.5% in the second quarter. BlackRock Inc. now owns 53,148,612 shares of the pharmacy operator’s stock valued at $3,189,715,000 after buying an additional 771,307 shares in the last quarter. Franklin Resources Inc. increased its stake in shares of Walgreens Boots Alliance by 21.5% in the third quarter. Franklin Resources Inc. now owns 18,789,390 shares of the pharmacy operator’s stock valued at $1,369,796,000 after buying an additional 3,318,524 shares in the last quarter. Finally, Capital World Investors increased its stake in shares of Walgreens Boots Alliance by 18.2% in the third quarter. Capital World Investors now owns 18,089,012 shares of the pharmacy operator’s stock valued at $1,318,689,000 after buying an additional 2,790,213 shares in the last quarter. 62.82% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Walgreens Boots Alliance (WBA) Issues Earnings Results” was originally reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://dakotafinancialnews.com/2018/12/20/walgreens-boots-alliance-wba-issues-earnings-results.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Story: Determine Your Level of Risk Tolerance

Earnings History for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply